Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 495,729 | 336,388 | 332,314 | 284,208 | 250,456 |
| Marketable Securities | 52,368 | 37,736 | 58,597 | 96,212 | 143,197 |
| Receivables | 876 | 761 | 642 | 1,247 | N/A |
| TOTAL | $553,876 | $386,644 | $398,061 | $387,131 | $396,561 |
| Non-Current Assets | |||||
| PPE Net | 2,283 | 2,413 | 2,488 | 1,754 | 1,783 |
| Investments And Advances | 67,097 | 15,242 | 5,484 | 7,056 | 17,546 |
| Other Non-Current Assets | 19,814 | 20,036 | 20,536 | 477 | 662 |
| TOTAL | $89,194 | $37,691 | $28,508 | $9,287 | $19,991 |
| Total Assets | $643,070 | $424,335 | $426,569 | $396,418 | $416,552 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,741 | 5,717 | 4,103 | 2,452 | 4,217 |
| Accrued Expenses | 12,853 | 14,075 | 15,958 | 11,826 | 15,262 |
| Other current liabilities | N/A | 1,097 | 555 | 197 | 342 |
| TOTAL | $16,099 | $20,889 | $20,616 | $14,475 | $19,821 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 270,543 | 19,838 | 20,222 | 0 | 0 |
| TOTAL | $270,543 | $19,838 | $20,222 | $N/A | $N/A |
| Total Liabilities | $286,642 | $40,727 | $40,838 | $14,475 | $19,821 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,672 | 27,508 | 27,433 | 27,369 | 27,366 |
| Common Shares | 28 | 27 | 27 | 27 | 27 |
| Retained earnings | -321,753 | -289,215 | -282,549 | -282,120 | -263,957 |
| Other shareholders' equity | -422 | -200 | -176 | -111 | -4 |
| TOTAL | $356,428 | $383,608 | $385,731 | $381,943 | $396,731 |
| Total Liabilities And Equity | $643,070 | $424,335 | $426,569 | $396,418 | $416,552 |